Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis.

Xia ZhangRuiling FengMiao ShaoYifan WangXiaolin SunJing He

Published in: Rheumatology and therapy (2021)

Low-dose IL-2 therapy may have a promising role in the treatment of refractory LN as an alternative and safe therapeutic approach. It may be used as multi-target combination therapy in clinical practice.

Keyphrases

combination therapy
low dose
clinical practice
high dose
stem cells
mesenchymal stem cells